Bridgefront Capital »

4d Molecular Therapeutics In shares owned by Bridgefront Capital

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Bridgefront Capital from 13F filings

Historical chart of Bridgefront Capital investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Bridgefront Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Bridgefront Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $214k 10k 20.99